-
Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Thursday, July 25, 2024 - 10:42pm | 603On Thursday, major U.S. indices showed mixed results. The Dow Jones Industrial Average increased by 0.2% to 39,935.07, while the S&P 500 fell by 0.5% to 5,399.22. The Nasdaq dropped 0.9% to 17,181.72. Let’s take a closer look at the top stocks that caught the attention of retail traders...
-
Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wednesday, July 24, 2024 - 10:40pm | 601On Wednesday, major U.S. indices closed significantly lower. The Dow Jones Industrial Average fell 1.25% to 39,853.87, the S&P 500 dropped 2.3% to 5,427.13, and the Nasdaq declined 3.6% to 17,342.41. These are the top stocks that gained the attention of retail traders and investors throughout...
-
Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tuesday, February 27, 2024 - 10:06pm | 569On Tuesday, the U.S. indices exhibited a varied performance, as the S&P 500 rose by nearly 0.2% to reach 5,078.18, while the Dow Jones Industrial Average dipped by 0.25% to settle at 38,972.41. Concurrently, the Nasdaq experienced a nearly 0.4% increase, reaching 16,035.30. These are the top...
-
Viking Therapeutics Gains 5% As Company Highlights Positive Data From A Phase 1b Clinical Trial
Monday, April 11, 2016 - 10:41am | 312Shares of Viking Therapeutics Inc (NASDAQ: VKTX), a clinical stage biopharmaceutical company that focuses on the treatment of metabolic and endocrine disorders, gained more than 5 percent on Monday. Viking Therapeutics highlighted positive data from a phase 1b clinical trial of VK2809 in...
-
Viking Therapeutics Shares Double Amid No News
Monday, December 28, 2015 - 5:51pm | 160Investors in nano-cap company Viking Therapeutics Inc (NASDAQ: VKTX) got quite a post-holiday surprise Monday as shares more than doubled over the trading session. The stock closed last week's session at $2.18; near Monday's closing bell, Viking Therapeutics had last traded at $4.43, up...